Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 637 KB, PDF-dokument

Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population-based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual-level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time-to-event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo-HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion-dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1-year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow-up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo-HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS.

OriginalsprogEngelsk
TidsskriftHematological Oncology
Vol/bind40
Udgave nummer5
Sider (fra-til)1056-1066
ISSN0278-0232
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This study was supported by grants from The Danish Cancer Society (Kræftens Bekæmpelse, grant number R223‐A13094‐18‐S68), The Danish Research Center for Equality in Cancer (COMPAS), the Dagmar Marshalls Foundation, and the Einer Willumsens Mindelegat. Kirsten Grønbæk is supported by grants from The Danish Cancer Society (Kræftens Bekæmpelse, grant no. R223‐A13071, the Danish Research Center for Precision Medicine in Blood Cancers).

Publisher Copyright:
© 2022 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.

ID: 321472740